5.1.3 Carnitine-acylcarnitine translocase (CACT) deficiency Clinical presentation Patients with CACT deficiency (OMIM 212138) usually present in the neonatal period with severe hyperammonemia, liver failure, cardiomyopathy and respiratory distress, often with fatal outcome [23, 24, 102, 103]
And then when that gets better, then you go back to your OAT, you go back to your mycotoxin screen to see what those are looking likeand they will change
It becomes something different
GPX specifically catalyses the reduction of lipid hydroperoxides (LOOHs) and organic hydroperoxides (ROOHs) through glutathione (GSH)-dependent reactions, thereby minimising oxidative damage and regulating prostaglandin biosynthesis [28]
In some embodiments, the otic formulation or composition comprises about 0.7% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof